Home » New Compounding Laws Don’t Change FDA Position on Makena
New Compounding Laws Don’t Change FDA Position on Makena
The FDA does not intend to prevent compounders from making preterm birth drug Makena, the agency says in a legal filing outlining how it intends to approach one contentious issue involving compounders.
Washington Drug Letter
Drugs Regulatory AffairsWashington Drug Letter
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May